•
Jun 30, 2015

Jazz Pharmaceuticals Q2 2015 Earnings Report

Total Revenue
$334M
Previous year: $291B
-99.9%
EPS
$2.41
Previous year: $0.75
+221.3%
Gross Profit
$312M
Previous year: $261M
+19.7%
Cash and Equivalents
$922M
Previous year: $268M
+243.6%
Total Assets
$3.39B
Previous year: $3.16B
+7.5%

Jazz Pharmaceuticals

Jazz Pharmaceuticals